JP2009540314A5 - - Google Patents

Download PDF

Info

Publication number
JP2009540314A5
JP2009540314A5 JP2009514827A JP2009514827A JP2009540314A5 JP 2009540314 A5 JP2009540314 A5 JP 2009540314A5 JP 2009514827 A JP2009514827 A JP 2009514827A JP 2009514827 A JP2009514827 A JP 2009514827A JP 2009540314 A5 JP2009540314 A5 JP 2009540314A5
Authority
JP
Japan
Prior art keywords
statin
standard
lipid
marker
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009514827A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009540314A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2007/050344 external-priority patent/WO2007144467A1/en
Publication of JP2009540314A publication Critical patent/JP2009540314A/ja
Publication of JP2009540314A5 publication Critical patent/JP2009540314A5/ja
Pending legal-status Critical Current

Links

JP2009514827A 2006-06-12 2007-06-12 筋障害診断方法 Pending JP2009540314A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81260206P 2006-06-12 2006-06-12
US87249506P 2006-12-04 2006-12-04
PCT/FI2007/050344 WO2007144467A1 (en) 2006-06-12 2007-06-12 Diagnostic method for myopathy

Publications (2)

Publication Number Publication Date
JP2009540314A JP2009540314A (ja) 2009-11-19
JP2009540314A5 true JP2009540314A5 (https=) 2010-07-29

Family

ID=38831439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514827A Pending JP2009540314A (ja) 2006-06-12 2007-06-12 筋障害診断方法

Country Status (4)

Country Link
US (1) US7611902B2 (https=)
EP (1) EP2029771A4 (https=)
JP (1) JP2009540314A (https=)
WO (1) WO2007144467A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137977B2 (en) * 2006-04-24 2012-03-20 Children's Hospital & Research Center At Oakland Lipidomic approaches to determining drug response phenotypes in cardiovascular disease
EP2529235B1 (en) * 2010-01-29 2019-03-06 Metanomics GmbH Means and methods for diagnosing heart failure in a subject
EP2558863B1 (en) * 2010-04-16 2015-10-07 The Johns Hopkins University Compositions and methods for characterizing a myopathy
NO2385374T3 (https=) * 2010-05-05 2014-06-07
AU2011260390B2 (en) * 2010-06-01 2016-11-24 Ernst-Moritz-Arndt Universitat Greifswald Means and methods for diagnosing pancreatic cancer in a subject
CN108445241B (zh) * 2010-06-20 2021-11-02 佐拉生物科学公司 用于鉴定高风险冠状动脉疾病患者的脂质组学标志
US9541565B2 (en) 2011-04-08 2017-01-10 Zora Biosciences Oy Biomarkers for sensitive detection of statin-induced muscle toxicity
EP2977764A1 (en) * 2011-04-08 2016-01-27 Zora Biosciences OY Biomarkers for sensitive detection of statin-induced muscle toxicity
JP5980900B2 (ja) * 2011-04-08 2016-08-31 ゾラ バイオサイエンシーズ オサケ ユキチュア スタチン誘発性筋毒性の高感度検出のためのバイオマーカー
JP6539511B2 (ja) * 2015-06-17 2019-07-03 花王株式会社 運動機能の判定用マーカー
JP2016191718A (ja) * 2016-07-27 2016-11-10 ゾラ バイオサイエンシーズ オサケ ユキチュア スタチン誘発性筋毒性の高感度検出のためのバイオマーカー
RU2641038C1 (ru) * 2017-03-06 2018-01-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) Способ диагностики врожденной миопатии центрального стержня

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003005628A2 (en) 2001-07-06 2003-01-16 Lipomics Technologies, Inc. Generating, viewing, interpreting, and utilizing a quantitative database of metabolites
ATE443264T1 (de) * 2001-09-24 2009-10-15 Lipomics Technologies Inc Verfahren zur verwendung von quantitativen lipidmetabolondaten
CA2459926A1 (en) * 2001-09-24 2003-04-03 Merck & Co., Inc. Screening and selection methods for statin drug combinations
AU2003225752A1 (en) * 2002-03-12 2003-09-29 Paul S. Phillips Method of diagnosing statin myopathy
US20060258003A1 (en) * 2002-12-13 2006-11-16 Celogos Culture medium composition, culture method, and myoblasts obtained, and their uses
US20050037946A1 (en) * 2003-01-13 2005-02-17 Millennium Pharmaceuticals, Inc. Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419
US20070202518A1 (en) * 2005-11-18 2007-08-30 Genomas, Inc. Physiogenomic method for predicting statin injury to muscle and muscle side effects
WO2007061995A2 (en) * 2005-11-21 2007-05-31 Novartis Ag Biomarkers for statin-induced myopathy or rhabdomyolysis

Similar Documents

Publication Publication Date Title
JP2009540314A5 (https=)
JP2009538607A5 (https=)
WO2005052592A3 (en) Methods for diagnosis, stratification, and monitoring of alzheimer’s disease
WO2007056560A3 (en) System and method for cytological analysis by raman spectroscopic imaging
EP1572091A4 (en) COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT
EP2306192A3 (en) Risk Markers For Cardiovascular Disease
EP2179025A4 (en) INTEGRATED DEVICE FOR CARRYING OUT NUCLEAR ACID EXTRACTIONS AND DIAGNOSTIC TESTS OF SEVERAL BIOLOGICAL SAMPLES
EP1578371A4 (en) COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT
EP2222355A4 (en) INTRADUCTAL DIAGNOSTIC AND THERAPEUTIC PROCEDURES FOR THE MEIBOMINE AND RELEVANT DEVICE
EP1780786A4 (en) STAGE DEVICE, EXPOSURE DEVICE AND EXPOSURE METHOD
ATE452343T1 (de) Verbesserte vitamin-d-messung
ATE514945T1 (de) Diagnoseverfahren für maul- und klauenseuche und diagnostischer kit
NO20070592L (no) Fremgangsmate for diagnostisering av prodromale former av sykdommer som er forbundet med amyloid avleiring.
EP2532748A3 (en) DNA aptamer specifically binding to human cardiac troponin I
JP2010506147A5 (https=)
NO20043246L (no) Nye fremgangsmater til diagnose og behandling av tumorer
SG171691A1 (en) Biomarkers for diagnosing multiple sclerosis, and methods thereof
JP2009524829A5 (https=)
EP1963840A4 (en) IMMUNOASSAY DEVICE AND KIT
WO2007000349A3 (en) Optical imaging of rheumatoid arthritis
JP2012189581A5 (https=)
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
EP1955726A4 (en) DISTRIBUTED MEDICAL INTRUMENT FOR PLACEMENT IN THE BODY, METHOD FOR PRODUCING THE MEDICAL INSTRUMENT FOR PLACEMENT IN THE BODY AND DEVICE FOR PRODUCING THE MEDICAL INSTRUMENT FOR PLACEMENT IN THE BODY
EP1929258A4 (en) PHOTOELECTRONIC SPECTROSCOPY DEVICE AND USE METHOD
EP2385375A3 (en) Development and use of fluorescent probes of unbound analytes